Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 398

1.

A survey of current practice of venous thromboembolism prophylaxis in hospitalized inflammatory bowel disease patients in the United States.

Tinsley A, Naymagon S, Trindade AJ, Sachar DB, Sands BE, Ullman TA.

J Clin Gastroenterol. 2013 Jan;47(1):e1-6. doi: 10.1097/MCG.0b013e31824c0dea.

PMID:
22476043
2.

Physicians' perceptions of risks and practices in venous thromboembolism prophylaxis in inflammatory bowel disease.

Sam JJ, Bernstein CN, Razik R, Thanabalan R, Nguyen GC.

Dig Dis Sci. 2013 Jan;58(1):46-52. doi: 10.1007/s10620-012-2435-6. Epub 2012 Oct 7.

PMID:
23053902
4.

Rates of pharmacologic venous thromboembolism prophylaxis in hospitalized patients with active ulcerative colitis: results from a tertiary care center.

Tinsley A, Naymagon S, Enomoto LM, Hollenbeak CS, Sands BE, Ullman TA.

J Crohns Colitis. 2013 Dec;7(12):e635-40. doi: 10.1016/j.crohns.2013.05.002. Epub 2013 May 22.

PMID:
23706933
5.

Consensus statements on the risk, prevention, and treatment of venous thromboembolism in inflammatory bowel disease: Canadian Association of Gastroenterology.

Nguyen GC, Bernstein CN, Bitton A, Chan AK, Griffiths AM, Leontiadis GI, Geerts W, Bressler B, Butzner JD, Carrier M, Chande N, Marshall JK, Williams C, Kearon C.

Gastroenterology. 2014 Mar;146(3):835-848.e6. doi: 10.1053/j.gastro.2014.01.042. Epub 2014 Jan 22. Review.

PMID:
24462530
6.

Venous thromboembolism in patients with inflammatory bowel diseases: a case-control study of risk factors.

Scoville EA, Konijeti GG, Nguyen DD, Sauk J, Yajnik V, Ananthakrishnan AN.

Inflamm Bowel Dis. 2014 Apr;20(4):631-6. doi: 10.1097/MIB.0000000000000007.

7.

Preventing venous thromboembolism in hospitalized patients with cancer: improving compliance with clinical practice guidelines.

Brown A.

Am J Health Syst Pharm. 2012 Mar 15;69(6):469-81. doi: 10.2146/ajhp110187. Review.

PMID:
22382477
8.

Prevention of venous thromboembolism in hospitalized patients with inflammatory bowel disease.

Chande N.

Inflamm Bowel Dis. 2013 Mar;19(3):669-71. doi: 10.1097/MIB.0b013e31827e7a0f. Review.

PMID:
23385239
9.

Predictors and safety of venous thromboembolism prophylaxis among hospitalized inflammatory bowel disease patients.

Ra G, Thanabalan R, Ratneswaran S, Nguyen GC.

J Crohns Colitis. 2013 Nov;7(10):e479-85. doi: 10.1016/j.crohns.2013.03.002. Epub 2013 Mar 26.

PMID:
23537817
10.

Prophylaxis against venous thromboembolism in hospitalized medically ill patients.

Pendergraft T, Liu X, Edelsberg J, Phatak H, Vera-Llonch M, Liu LZ, Oster G.

Circ Cardiovasc Qual Outcomes. 2013 Jan 1;6(1):75-82. doi: 10.1161/CIRCOUTCOMES.112.965939. Epub 2013 Jan 8.

11.

Practice of gastroenterologists in treating flaring inflammatory bowel disease patients with clostridium difficile: antibiotics alone or combined antibiotics/immunomodulators?

Yanai H, Nguyen GC, Yun L, Lebwohl O, Navaneethan U, Stone CD, Ghazi L, Moayyedi P, Brooks J, Bernstein CN, Ben-Horin S.

Inflamm Bowel Dis. 2011 Jul;17(7):1540-6. doi: 10.1002/ibd.21514. Epub 2010 Nov 18.

PMID:
21674710
12.

Asian venous thromboembolism guidelines: prevention of venous thromboembolism.

Liew NC, Chang YH, Choi G, Chu PH, Gao X, Gibbs H, Ho CO, Ibrahim H, Kim TK, Kritpracha B, Lee LH, Lee L, Lee WY, Li YJ, Nicolaides AN, Oh D, Pratama D, Ramakrishnan N, Robless PA, Villarama-Alemany G, Wong R; Asian Venous Thrombosis Forum.

Int Angiol. 2012 Dec;31(6):501-16. Review.

PMID:
23222928
13.

Venous thromboembolism and underutilisation of anticoagulant thromboprophylaxis in hospitalised patients with inflammatory bowel disease.

Dwyer JP, Javed A, Hair CS, Moore GT.

Intern Med J. 2014 Aug;44(8):779-84. doi: 10.1111/imj.12488.

PMID:
24893756
14.

Thrombosis in inflammatory bowel disease: are we tailoring prophylaxis to those most at risk?

Bryant RV, Jairath V, Curry N, Travis SP.

J Crohns Colitis. 2014 Feb;8(2):166-71. doi: 10.1016/j.crohns.2013.09.007. Epub 2013 Oct 4.

PMID:
24095288
15.

A cross-sectional evaluation of venous thromboembolism risk and use of venous thromboembolism prophylaxis in hospitalized patients in Senegal.

Bâ SA, Badiane SB, Diop SN, Diouf FS, Fall D, Ka MM, Kane A, Ndiaye M; Comité TROMBUS Senegal.

Arch Cardiovasc Dis. 2011 Oct;104(10):493-501. doi: 10.1016/j.acvd.2011.05.007. Epub 2011 Sep 1.

16.

Rising prevalence of venous thromboembolism and its impact on mortality among hospitalized inflammatory bowel disease patients.

Nguyen GC, Sam J.

Am J Gastroenterol. 2008 Sep;103(9):2272-80. doi: 10.1111/j.1572-0241.2008.02052.x. Epub 2008 Aug 5.

PMID:
18684186
17.

Pharmacologic prophylaxis for venous thromboembolism and 30-day outcomes among older patients hospitalized with heart failure: an analysis from the ADHERE national registry linked to Medicare claims.

Kociol RD, Hammill BG, Hernandez AF, Klaskala W, Mills RM, Curtis LH, Fonarow GC.

Clin Cardiol. 2011 Nov;34(11):682-8. doi: 10.1002/clc.20986. Epub 2011 Nov 6.

18.

Thromboprophylaxis rates in US medical centers: success or failure?

Amin A, Stemkowski S, Lin J, Yang G.

J Thromb Haemost. 2007 Aug;5(8):1610-6.

19.
20.

Feasibility of venous thromboembolism prophylaxis during inflammatory bowel disease flares in the outpatient setting: a decision analysis.

Nguyen GC, Sharma S.

Inflamm Bowel Dis. 2013 Sep;19(10):2182-9. doi: 10.1097/MIB.0b013e31829c01ef.

PMID:
23883960

Supplemental Content

Support Center